<p>Cardiac Surgery-associated acute kidney injury (CS-AKI) is a common complication in children. Comparison of studies over the last 2 decades has been difficult because of varying definitions and practice heterogeneity. Multiple risk factors exist; however, few are modifiable. Limitations in serum creatinine and urine output have hampered precision in CS-AKI diagnosis. Delineating CS-AKI using durational, biomarker-based, and fluid sub-phenotypes has strengthened associations with outcomes. Despite the significant short and long-term effects of CS-AKI, no study has proven efficacious for its prevention or treatment. Targeted early risk stratification tools should be considered for prognostication and possible clinical trial enrichment. Long-term consequences of CS-AKI need further study, given the inconsistency in findings, through systematic follow-up of these high-risk patients.</p>

错误:搜索内容不能为空,请输入英文关键词
错误:关键词超出字数限制,请精简
高级检索

Each nephron is worth every heartbeat: navigating acute kidney injury in children post-cardiac surgery

  • Zaccaria M. Ricci,
  • Andrea Cappoli,
  • Tiziana Fragasso,
  • Marco Daverio,
  • Alex Lepage-Farrell,
  • Isabella Guzzo,
  • Serge Grazioli,
  • Katja M. Gist

摘要

Cardiac Surgery-associated acute kidney injury (CS-AKI) is a common complication in children. Comparison of studies over the last 2 decades has been difficult because of varying definitions and practice heterogeneity. Multiple risk factors exist; however, few are modifiable. Limitations in serum creatinine and urine output have hampered precision in CS-AKI diagnosis. Delineating CS-AKI using durational, biomarker-based, and fluid sub-phenotypes has strengthened associations with outcomes. Despite the significant short and long-term effects of CS-AKI, no study has proven efficacious for its prevention or treatment. Targeted early risk stratification tools should be considered for prognostication and possible clinical trial enrichment. Long-term consequences of CS-AKI need further study, given the inconsistency in findings, through systematic follow-up of these high-risk patients.